Kirsten Dahl

Novo Nordisk (Denmark) — Denmark

Medicine · Health Sciences

15h-index982citations47works7.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(15), Metabolism, Diabetes, and Cancer(9), Diet and metabolism studies(9), Xenotransplantation and immune response(7), Regulation of Appetite and Obesity(5)

Publications47 total

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Long‐Acting FGF21 Analog Zalfermin
Clinical and Translational Science·2025Open Access
Sécurité et perte de poids avec l’amycrétine orale : un co-agoniste des récepteurs de l’amyline et du GLP-1
Annales d Endocrinologie·2025
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
The Lancet·2025· 33 cited
2002-LB: Amycretin, a Novel, Unimolecular GLP-1 and Amylin Receptor Agonist—Results of a Phase 1b/2a Clinical Trial
Diabetes·2025
Correction to “NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin”
Journal of Medicinal Chemistry·2024· 1 citedOpen Access
NN1213 – A Potent, Long-Acting, and Selective Analog of Human Amylin
Journal of Medicinal Chemistry·2024· 10 citedOpen Access
Reduced triglycerides and LDL cholesterol from once-weekly administration of the well-tolerated novel FGF21 analogue 0499
Journal of Hepatology·2022· 1 cited
Sustained reduction of triglyceride and LDL cholesterol from single administration of the novel long-acting FGF21 analogue 0499
Journal of Hepatology·2022
In Vitro CYP450 Enzyme Downregulation by GLP-1/Glucagon Coagonist Does Not Translate to Observed Drug-Drug Interactions in the Clinic
Drug Metabolism and Disposition·2022· 15 citedOpen Access
Development of Cagrilintide, a Long-Acting Amylin Analogue
Journal of Medicinal Chemistry·2021· 108 cited
Response to the letter from Horowitz et al. to the Editor relating to the publication ‘Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes’ by Dahl et al.
Diabetes Obesity and Metabolism·2021· 1 cited
Author response for "Response to the letter from Horowitz et al to the Editor relating to the publication ‘Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes’ by Dahl et al"
2021
AM833, a Long Acting Amylin Analogue Induces Hypocalcemia in Young Rats via a Calcitonin Receptor Mediated Mechanism
Journal of the Endocrine Society·2021Open Access
Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type <scp>2</scp> diabetes
Diabetes Obesity and Metabolism·2021· 73 citedOpen Access
Author response for "Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes"
2021
Author response for "Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes"
2021Open Access
Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes
Diabetes Obesity and Metabolism·2020· 110 citedOpen Access
Author response for "Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes"
2020
Author response for "Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes"
2020Open Access
Effects of semaglutide on beta cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial
Diabetologia·2017· 104 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Axel Kornerup Hansen(9), Tine A. Bækdal(8), Søren T. Hoff(6), Kirsten Raun(6), Cassandra Key(5), Dorte Bratbo Sørensen(5), Rikke Bjerring Skyggebjerg(4), Mads Axelsen(4), Ashley Brooks(4), Firas Almazedi(4), Cristina Boschini(4), Søren Toubro(4), Svend Kirkeby(4), Christian Poulsen(3), Morten Schlein(3), Ann Maria Kruse Hansen(3), Charlotta Dornonville de la Cour(3), Trine Ryberg Clausen(3), Anne Flint(3), Birgitte Dissing Andersen(3)